Rare diseases
Investigational molecules
Locations
Back to Belgium1 clinical trial in Gosselies, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Ongoing studies focusing on SARS-CoV-2 immunity patterns in vulnerable populations, particularly examining antibody responses in immunocompromised individuals.
The research encompasses diverse patient groups including nursing home residents, dialysis patients, and transplant recipients, providing valuable insights into COVID-19 immunity in at-risk populations.
Specialized investigation of immune responses in kidney and lung transplant patients, contributing to understanding COVID-19 vulnerability in transplant recipients.
This longitudinal study in Belgium aims to enhance protective strategies for transplant recipients during the pandemic.
Comprehensive evaluation of COVID-19 immunity in elderly populations, with special attention to nursing home residents.
Research focused on understanding immune system responses in older adults to improve prevention strategies.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
